Καπνοβιομηχανια Καρελια Α.ε.
Greece · GRS120003009 · reports in EUR · Europe
The answers
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Is it growing?Good
- Revenue +11% in the year to Dec 31, 2025, on the year before.
- Is it a good business?Fair
- It earned 12% on its shareholders' equity in the year to Dec 31, 2025.
- Is it safe?Good
- Equity is 83% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in EUR.
€1.7B
revenue
8.0%
operating margin
€103M
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | €1.3B | €1.3B | €1.5B | €1.7B |
| Operating profit | €103M | €97M | €105M | €133M |
| Net profit to shareholders | €85M | €87M | €113M | €103M |
| Earnings per share | €30.93 | €31.47 | €40.87 | €37.42 |
| Cash from operations | €137M | €75M | €92M | €93M |
| Capital spending | €1M | €3M | €2M | €5M |
| Cash | €366M | €322M | n/a | n/a |
| Total assets | €798M | €863M | €953M | €1.0B |
| Equity | €659M | €713M | €792M | €856M |
What they do
In the company's own words, from the annual report.
παραγωγή και εμπορία καπνοβιομηχανικών προϊόντων
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.